Abiopharma

Nuvation Bio Inc. - Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI®(taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer

Halozyme - Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™Technology

Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Liberty Global Tech Ventures Announces Investment in AI Security Firm, XBOW

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Tenet - Tenet to Participate in the BofA Securities Health Care Conference

Prospectus

Annexon to Present at the Bank of America Securities Health Care Conference 2026